TriMas (NASDAQ:TRS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at BWS Financial in a research note issued on Thursday,Benzinga reports. They currently have a $40.00 target price on the industrial products company’s stock. BWS Financial’s price objective would suggest a potential upside of 63.33% from the company’s current price.
Separately, StockNews.com raised TriMas from a “sell” rating to a “hold” rating in a research report on Wednesday, November 13th.
View Our Latest Stock Analysis on TRS
TriMas Price Performance
TriMas (NASDAQ:TRS – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The firm had revenue of $229.36 million during the quarter, compared to the consensus estimate of $239.33 million. During the same quarter in the previous year, the business posted $0.57 earnings per share. The firm’s quarterly revenue was down 2.5% on a year-over-year basis. On average, analysts anticipate that TriMas will post 1.69 earnings per share for the current year.
Institutional Investors Weigh In On TriMas
A number of hedge funds have recently made changes to their positions in the business. Aristides Capital LLC purchased a new position in TriMas during the 2nd quarter valued at $245,000. Intech Investment Management LLC purchased a new position in TriMas during the 3rd quarter valued at $269,000. Paloma Partners Management Co purchased a new position in TriMas during the 3rd quarter valued at $293,000. XTX Topco Ltd purchased a new position in TriMas during the 3rd quarter valued at $371,000. Finally, Algert Global LLC increased its position in TriMas by 4.2% during the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 639 shares during the period. 99.42% of the stock is currently owned by institutional investors.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More
- Five stocks we like better than TriMas
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
- Bank Stocks – Best Bank Stocks to Invest In
- GitLab: AI-Driven DevSecOps Innovation Sets It Apart
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- DigitalOcean’s AI Potential: A Game-Changer for Growth
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.